Newsroom

Newsroom

NEWS

June 6, 2024

GSK accelerates oligonucleotide platform and pipeline medicines with acquisition of Elsie Biotechnologies

By GSK

Read more:

NEWS

February 14, 2024

GSK still has a crush on oligonucleotides, sealing the deal with Elsie

By Fierce Biotech

Read more:

PRESS RELEASE

February 14, 2024

GSK Exercises Option to License Elsie Biotechnologies’ Discovery Platform to Find and Develop Novel Oligonucleotides

By Elsie Biotechnologies

Read more:

PRESS RELEASE

November 6, 2023

Elsie Biotechnologies Announces First Peer-Reviewed Publication

By Elsie Biotechnologies

Read more:

NEWS

July 10, 2023

GSK Dives Even Deeper Into Oligo Strategy With Elsie Biotechnology Pair-ups

By Fierce Biotech

Read more:

PRESS RELEASE

July 10, 2023

Elsie Biotechnologies Announces Collaboration with GSK to Accelerate Oligonucleotide Discovery Technologies

By Elsie Biotechnologies

Read more:

PRESS RELEASE

June 27, 2022

Elsie’s Technology Awarded 2022 Organic Division Horizon Prize from Royal Society of Chemistry

By Elsie Biotechnologies

Read more:

PRESS RELEASE

August 20, 2021

Elsie’s Technology Awarded 2021 U.S. Environmental Protection Agency’s (EPA) Prestigious Green Chemistry Challenge Award